Space-filling intragastric implants with fluid flow
A variety of passive intragastric implant devices for obesity treatment are disclosed. Such passive devices do not autonomously change shape, but instead react within the stomach to induce satiety. The devices may take up volume within the stomach, thus reducing the intake capacity. Additionally, the devices may contact areas within the stomach, such as the cardia surrounding the esophageal sphincter, to stimulate satiety-inducing nerves. Also, certain devices slow gastric emptying by blocking or otherwise impeding flow through the pyloric sphincter. A number of devices combine two or more of these satiety-inducing features. Methods of implant are disclosed including compressing the devices within a delivery tube and transorally advancing the devices through the esophagus to be deployed within the stomach. Removal of the devices occurs in the reverse.
1. A passive intragastric obesity treatment implant, comprising:
an inflatable body having a length sufficient to extend between the esophageal sphincter at a superior end of the body and the pyloric sphincter at an inferior end of the body upon implant in the stomach, and a width sufficient to contact the interior stomach walls upon contraction thereof, the body being rounded and slightly tapered so as to generally conform to the volume of an adult stomach cavity, the body including a series of chambers fluidly connected so as to be capable of simultaneous inflation and deflation, wherein two chambers at the superior end are separated from each other by an annular recess that is positioned to open to the esophageal sphincter, and wherein apertures in the annular recess open to a central flow channel that extends from the annular recess to the inferior end of the body, wherein the central flow channel extends through at least two chambers between the annular recess and the inferior end of the body,
the implant being formed of a material which permits it to be compressed into a substantially linear delivery configuration and that will resist degradation over a period of at least six months within the stomach.
2. The implant of claim 1 , wherein the central flow channel has a star-shaped cross-section.
3. The implant of claim 1 , wherein the chambers gradually decrease in diameter from the superior to the inferior ends of the body.
4. The implant of claim 1 , wherein the body includes a rounded superior end that mimics the shape of the surrounding cardia and defines a proximal chamber therein.
5. The implant of claim 1 , wherein an outer surface of the inflatable body includes uneven surface features.
6. The implant of claim 5 , wherein the uneven surface features include at least one of a rounded bump or protrusion, quill-like extension, flagella, dimple, and recess.
7. The implant of claim 6 , wherein the uneven surface features are equally spaced from each other along the outer surface of the inflatable body.
8. The implant of claim 6 , wherein the uneven surface features have different heights.
9. The implant of claim 6 , wherein the uneven surface features flex in response to a pressure being exerted on them from the inner stomach wall of the patient.
10. The implant of claim 5 , wherein the uneven surface features are constructed to contact the inner stomach to trigger hormone release.
11. The implant of claim 5 , wherein the uneven surface features are constructed to contact the inner stomach to stimulate the cardia.
12. A passive intragastric obesity treatment implant, comprising:
an inflatable body having a length sufficient to extend between the esophageal sphincter at a superior end of the body and the pyloric sphincter at an inferior end of the body upon implant in the stomach, and a width sufficient to contact the interior stomach walls upon contraction thereof, the body being rounded and slightly tapered so as to generally conform to the volume of an adult stomach cavity, the body including a series of chambers fluidly connected so as to be capable of simultaneous inflation and deflation, wherein two chambers at the superior end are separated by an annular recess that is positioned to open to the esophageal sphincter, and wherein apertures in the annular recess open to a central flow channel that extends from the annular recess to the inferior end of the body, and some of the chambers surround the central flow channel,
the implant being formed of a material which permits it to be compressed into a substantially linear delivery configuration and that will resist degradation over a period of at least six months within the stomach,
wherein a plurality of circumferential grooves extend around the body and between adjacent chambers, and wherein radial passages connect the circumferential grooves to the central flow channel.
13. A passive intragastric obesity treatment implant, comprising:
an inflatable body having a length sufficient to extend between the esophageal sphincter at a superior end of the body and the pyloric sphincter at an inferior end of the body upon implant in the stomach, and a width sufficient to contact the interior stomach walls upon contraction thereof, the body being rounded and slightly tapered so as to generally conform to the volume of an adult stomach cavity, the body including a series of annular chambers in fluid communication with an inner longitudinal channel that extends through the annular chambers for simultaneous inflation and deflation of the annular chambers, wherein the chamber at the superior end is longitudinally spaced from a proximal chamber of the body by an annular recess that is positioned to be open to the esophageal sphincter, and wherein transverse flow channels are formed in the annular recess that extend to the inner longitudinal channel in a direction transverse to the longitudinal channel, wherein the longitudinal channel extends from the annular recess to the inferior end of the body, wherein the longitudinal flow channel extends through at least two chambers between the annular recess and the inferior end of the body,
the implant being formed of a material which permits it to be compressed into a substantially linear delivery configuration and that will resist degradation over a period of at least six months within the stomach.
14. The implant of claim 13 , wherein the annular chambers gradually decrease in outer diameter from the superior to the inferior ends of the body.
15. The implant of claim 13 , wherein the body includes a rounded superior end that mimics the shape of the inner wall of the surrounding cardia and defines a proximal chamber therein.
16. The implant of claim 13 , wherein an outer surface of the inflatable body includes uneven surface features.
17. The implant of claim 16 , wherein the uneven surface features include at least one of a rounded bump or protrusion, quill-like extension, flagella, dimple, and recess.
18. The implant of claim 17 , wherein the uneven surface features are equally spaced from each other along the outer surface of the inflatable body.
19. The implant of claim 17 , wherein the uneven surface features have different heights.
20. The implant of claim 17 , wherein the uneven surface features flex in response to a pressure being exerted on them from the inner stomach wall of the patient.
21. The implant of claim 16 , wherein the uneven surface features are constructed to contact the inner stomach to trigger hormone release.
22. The implant of claim 16 , wherein the uneven surface features are constructed to contact the inner stomach to stimulate the cardia.
23. A passive intragastric obesity treatment implant, comprising:
an inflatable body having a length sufficient to extend between the esophageal sphincter at a superior end of the body and the pyloric sphincter at an inferior end of the body upon implant in the stomach, and a width sufficient to contact the interior stomach walls upon contraction thereof, the body being rounded and slightly tapered so as to generally conform to the volume of an adult stomach cavity, the body including a series of annular chambers in fluid communication with an inner longitudinal channel that extends through the annular chambers for simultaneous inflation and deflation of the annular chambers, wherein the chamber at the superior end is longitudinally spaced from a proximal chamber of the body by an annular recess that is positioned to open to the esophageal sphincter, and wherein transverse flow channels are formed in the annular recess that extend to the inner longitudinal channel in a direction transverse to the longitudinal channel, wherein the longitudinal channel extends from the annular recess to the inferior end of the body,
the implant being formed of a material which permits it to be compressed into a substantially linear delivery configuration and that will resist degradation over a period of at least six months within the stomach, wherein the inner longitudinal channel has a star-shaped cross-section.
24. A passive intragastric obesity treatment implant, comprising:
an inflatable body having a length sufficient to extend between the esophageal sphincter at a superior end of the body and the pyloric sphincter at an inferior end of the body upon implant in the stomach, and a width sufficient to contact the interior stomach walls upon contraction thereof, the body being rounded and slightly tapered so as to generally conform to the volume of an adult stomach cavity, the body including a series of annular chambers in fluid communication with an inner longitudinal channel that extends through the annular chambers for simultaneous inflation and deflation of the annular chambers, wherein the chamber at the superior end is longitudinally spaced from a proximal chamber of the body by an annular recess that is positioned to open to the esophageal sphincter, and wherein transverse flow channels are formed in the annular recess that extend to the inner longitudinal channel in a direction transverse to the longitudinal channel, wherein the longitudinal channel extends from the annular recess to the inferior end of the body,
the implant being formed of a material which permits it to be compressed into a substantially linear delivery configuration and that will resist degradation over a period of at least six months within the stomach, wherein a plurality of circumferential grooves extend around the body and between adjacent annular chambers, and wherein transverse passages connect the circumferential grooves to the inner longitudinal channel.